Genocea Biosciences Company

Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.

Total Funding: 470569774
Headquarters: Cambridge, Massachusetts, United States
Funding Status: IPO
Employee Number: 51-100
Estimated Revenue: $10M to $50M
Last Funding Type: Post-IPO Equity
Last Funding Date: 2020-07-22
Investors Number: 13
Founded Date: 2006-01-01
Industry: Atrificial Vectors and Immune Cells